| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals, Inc. | MAIER PAUL V | Director | Nov 15, 2018 | Buy | $6.00 | 5,000 | 30,000 | 59,745 | Nov 15, 2018, 07:13 PM | |
| MBVX | MABVAX THERAPEUTICS HOLDINGS, INC. | MAIER PAUL V | Director | Jan 23, 2018 | Sale | $0.87 | 17,449 | 15,181 | 86,313 | Jan 24, 2018, 07:09 PM | |
| MBVX | MABVAX THERAPEUTICS HOLDINGS, INC. | MAIER PAUL V | Director | Jan 24, 2018 | Sale | $0.84 | 17,999 | 15,119 | 68,314 | Jan 24, 2018, 07:09 PM | |
| APRI | APRICUS BIOSCIENCES, INC. | MAIER PAUL V | Director | Sep 30, 2016 | Option Exercise | $0.34 | 10,715 | 3,625 | 26,039 | Oct 03, 2016, 04:33 PM | |
| APRI | APRICUS BIOSCIENCES, INC. | MAIER PAUL V | Director | Jun 30, 2016 | Option Exercise | $0.40 | 9,074 | 3,625 | 15,324 | Jul 01, 2016, 08:27 PM | |
| APRI | APRICUS BIOSCIENCES, INC. | MAIER PAUL V | Director | Apr 05, 2016 | Option Exercise | $0.58 | 6,250 | 3,625 | 6,250 | Apr 07, 2016, 04:50 PM | |
| MBVX | MABVAX THERAPEUTICS HOLDINGS, INC. | MAIER PAUL V | Director | May 29, 2015 | Buy | $2.30 | 5,000 | 11,500 | 5,000 | Jun 02, 2015, 03:46 PM | |
| SQNM | SEQUENOM INC | MAIER PAUL V | Chief Financial Officer | Feb 10, 2014 | Option Exercise | $2.34 | 3,138 | 7,343 | 63,789 | Feb 12, 2014, 12:37 PM | |
| PURE | PURE BIOSCIENCE, INC. | MAIER PAUL V | Director | Jul 31, 2012 | Option Exercise | $0.38 | 13,710 | 5,210 | 69,110 | Aug 02, 2012, 06:59 PM | |
| SQNM | SEQUENOM INC | MAIER PAUL V | Chief Financial Officer | Aug 01, 2012 | Buy | $2.86 | 10,000 | 28,634 | 10,000 | Aug 02, 2012, 05:47 PM | |
| PURE | PURE BIOSCIENCE, INC. | MAIER PAUL V | Director | Jan 21, 2011 | Option Exercise | $2.13 | 13,300 | 28,329 | 55,400 | Aug 26, 2011, 04:48 PM | |
| PURE | PURE BIOSCIENCE | MAIER PAUL V | Director | Jan 21, 2011 | Option Exercise | $2.13 | 13,300 | 28,329 | 57,400 | Jan 25, 2011, 05:12 PM |
Menu